We are live on ! Find out more
P8IP

Pier 88 Investment Partners Portfolio holdings

AUM $421M
1-Year Est. Return 14.71%
This Fund
S&P 500
This Quarter Est. Return
+15.32%
1 Year Est. Return
+14.71%
3 Year Est. Return
+36.1%
5 Year Est. Return
+43.13%
10 Year Est. Return
AUM
$352M
AUM Growth
+$77.8M
Cap. Flow
-$109M
Cap. Flow %
-30.85%
Top 10 Hldgs %
32.55%
Holding
122
New
21
Increased
31
Reduced
23
Closed
11
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZEN
26
DELISTED
ZENDESK INC
ZEN
$1.69M 0.48%
19,080
+463
+2% +$35.6K
ZS icon
27
Zscaler
ZS
$28.6B
$1.68M 0.48%
15,375
+6,475
+73% +$538K
DOCU
28
DocuSign
DOCU
$11.4B
$1.67M 0.47%
9,668
-6,062
-39% -$764K
DXCM icon
29
DexCom
DXCM
$33.1B
$1.66M 0.47%
16,408
+1,168
+8% +$104K
HZNP
30
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.66M 0.47%
29,881
-5,009
-14% -$214K
CHGG icon
31
Chegg
CHGG
$94.8M
$1.65M 0.47%
24,494
-12,131
-33% -$648K
OTRK
32
DELISTED
Ontrak
OTRK
$1.58M 0.45%
710
+100
+16% +$201K
CRSP icon
33
CRISPR Therapeutics
CRSP
$5.17B
$1.52M 0.43%
20,647
+10,317
+100% +$603K
COUP
34
DELISTED
Coupa Software Incorporated
COUP
$1.47M 0.42%
+5,317
New +$1.07M
TREX icon
35
Trex
TREX
$4.91B
$1.47M 0.42%
22,542
+8,582
+61% +$458K
WORK
36
DELISTED
Slack Technologies, Inc.
WORK
$1.46M 0.41%
+46,878
New +$1.41M
IMMU
37
DELISTED
Immunomedics Inc
IMMU
$1.41M 0.4%
39,814
+1,154
+3% +$33.7K
LVGO
38
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$1.41M 0.4%
+18,730
New +$980K
FRPT icon
39
Freshpet
FRPT
$3.26B
$1.37M 0.39%
+16,408
New +$1.23M
RARE icon
40
Ultragenyx Pharmaceutical
RARE
$2.64B
$1.29M 0.37%
16,515
+1,850
+13% +$122K
DNLI icon
41
Denali Therapeutics
DNLI
$4B
$1.26M 0.36%
52,309
+4,609
+10% +$108K
CHWY icon
42
Chewy
CHWY
$9.25B
$1.23M 0.35%
+27,495
New +$1.2M
INOV
43
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$1.21M 0.35%
+63,015
New +$1.12M
QQQ icon
44
Invesco QQQ Trust
QQQ
$479B
$1.21M 0.34%
+4,900
New +$1.1M
SFIX
45
Stitch Fix
SFIX
$530M
$1.2M 0.34%
48,246
+8,581
+22% +$169K
GLUU
46
DELISTED
Glu Mobile Inc.
GLUU
$1.18M 0.34%
127,367
+60,187
+90% +$512K
EFOR
47
Everforth Inc
EFOR
$1.33B
$1.17M 0.33%
17,570
+3,505
+25% +$186K
PODD icon
48
Insulet
PODD
$9.91B
$1.14M 0.32%
5,858
+1,128
+24% +$216K
TNET icon
49
TriNet
TNET
$3.09B
$1.11M 0.32%
+18,231
New +$911K
WIX icon
50
WIX.com
WIX
$2.61B
$1.01M 0.29%
3,935
-4,870
-55% -$864K

Similar funds

Pier 88 Investment Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Pier 88 Investment Partners held 122 positions worth $352M, up 28% from $274M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Pier 88 Investment Partners withdrew a net $109M in Q2 2020, closing 11 positions and reducing 23 holdings. Its most notable exit was Stanley Black & Decker, Inc. Corporate Units, an estimated $5.91M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 5.9% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Pier 88 Investment Partners opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $9.07M.

  • Pier 88 Investment Partners's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 86,580 shares worth $9.07M.
  • Pier 88 Investment Partners added most to Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, an estimated $3.91M increase.
  • Pier 88 Investment Partners's biggest Q2 2020 reduction was Bank of America Series L, cutting an estimated $4.1M.
  • Pier 88 Investment Partners fully exited Stanley Black & Decker, Inc. Corporate Units in Q2 2020, selling an estimated $5.91M.
  • Pier 88 Investment Partners's ten largest holdings make up 33% of its $352M portfolio in Q2 2020.
  • Pier 88 Investment Partners opened 21 new positions and closed 11 in Q2 2020.
  • Pier 88 Investment Partners's portfolio value rose 28% quarter-over-quarter to $352M.

Based on Pier 88 Investment Partners's 13F filing for Q2 2020, filed 14 Aug 2020.